Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Extra-Neutralizing FcR-Mediated Antibody Functions for a Universal Influenza Vaccine
Carolyn M. Boudreau, Galit Alter
Frontiers in Immunology (2019) Vol. 10
Open Access | Times Cited: 81

Showing 51-75 of 81 citing articles:

Ad26.COV2.S priming provided a solid immunological base for mRNA-based COVID-19 booster vaccination
Daryl Geers, Roos S. G. Sablerolles, Debbie van Baarle, et al.
iScience (2022) Vol. 26, Iss. 1, pp. 105753-105753
Open Access | Times Cited: 7
Challenges for the Newborn Immune Response to Respiratory Virus Infection and Vaccination
Kali F. Crofts, Martha A. Alexander‐Miller
Vaccines (2020) Vol. 8, Iss. 4, pp. 558-558
Open Access | Times Cited: 11
Heterosubtypic Protection Induced by a Live Attenuated Influenza Virus Vaccine Expressing Galactose-α-1,3-Galactose Epitopes in Infected Cells
Li-Meng Yan, Sylvia P. N. Lau, Chek Meng Poh, et al.
mBio (2020) Vol. 11, Iss. 2
Open Access | Times Cited: 10
Structural basis for cross-group recognition of an influenza virus hemagglutinin antibody that targets postfusion stabilized epitope
Keisuke Tonouchi, Yu Adachi, Tateki Suzuki, et al.
PLoS Pathogens (2023) Vol. 19, Iss. 8, pp. e1011554-e1011554
Open Access | Times Cited: 3
Influenza Vaccination Results in Differential Hemagglutinin Stalk-Specific Fc-Mediated Functions in Individuals Living With or Without HIV
Boitumelo M. Motsoeneng, Nisha Dhar, Marta C. Nunes, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 5
Fc-Effector-Independent in vivo Activity of a Potent Influenza B Neuraminidase Broadly Neutralizing Antibody
Ahmed Magdy Khalil, Michael S. Piepenbrink, Ian Markham, et al.
Viruses (2023) Vol. 15, Iss. 7, pp. 1540-1540
Open Access | Times Cited: 2
Influenza immune imprinting synergizes PEI-HA/CpG nanoparticle vaccine protection against heterosubtypic infection in mice
Chunhong Dong, Yao Ma, Wandi Zhu, et al.
Vaccine (2023) Vol. 42, Iss. 2, pp. 111-119
Closed Access | Times Cited: 2
FcγR Genetic Variation and HIV-1 Vaccine Efficacy: Context And Considerations
Ria Lassaunière, Caroline T. Tiemessen
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 6
Dissecting Fc signatures of protection in neonates following maternal influenza vaccination in a placebo-controlled trial
Carolyn M. Boudreau, John S. Burke, Kiel Shuey, et al.
Cell Reports (2022) Vol. 38, Iss. 6, pp. 110337-110337
Open Access | Times Cited: 4
Class switch towards non-inflammatory IgG isotypes after repeated SARS-CoV-2 mRNA vaccination
Pascal Irrgang, Juliane Gerling, Katharina Kocher, et al.
medRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access | Times Cited: 4
Low quality antibody responses in critically ill patients hospitalized with pandemic influenza A(H1N1)pdm09 virus infection
Xiuhua Lu, Zhu Guo, Zhu‐Nan Li, et al.
Scientific Reports (2022) Vol. 12, Iss. 1
Open Access | Times Cited: 4
Fc mediated pan-sarbecovirus protection after alphavirus vector vaccination
Lily E. Adams, Sarah R. Leist, Kenneth H. Dinnon, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access | Times Cited: 4
Bacteriophage T4 Vaccine Platform for Next-generation Influenza Vaccine Development
Mengling Li, Pengju Guo, Cen Chen, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2021)
Open Access | Times Cited: 5
IgG Subclass Switch in Volunteers Repeatedly Immunized with the Full-Length Plasmodium falciparum Merozoite Surface Protein 1 (MSP1)
Veronika Rathay, Kristin Fürle, Viktoria Kiehl, et al.
Vaccines (2024) Vol. 12, Iss. 2, pp. 208-208
Open Access
Repeated vaccination with homologous influenza hemagglutinin broadens human antibody responses to unmatched flu viruses.
Yixiang Deng, Melbourne Tang, Ted M. Ross, et al.
medRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Wie impfe ich im Alter bzw. bei anderen Risikogruppen und sollte man den Impferfolg kontrollieren?
Marco Krasselt
Arthritis und Rheuma (2024) Vol. 44, Iss. 03, pp. 181-189
Closed Access
Protection against the H1N1 influenza virus using self-assembled nanoparticles formed by lumazine synthase and bearing the M2e peptide
Hechao Zhu, Xinxin Li, Xiangmin Li, et al.
Virology (2024) Vol. 597, pp. 110162-110162
Closed Access
Meeting Report From “Correlates of Protection for Next Generation Influenza Vaccines: Lessons Learned From the COVID‐19 Pandemic”
Florian Krammer, Jacqueline M. Katz, Othmar G. Engelhardt, et al.
Influenza and Other Respiratory Viruses (2024) Vol. 18, Iss. 10
Open Access
Antibody-dependent cell-mediated cytotoxicity antibody responses to inactivated and live-attenuated influenza vaccination in children during 2014–15
Kelsey R. Florek, James Mutschler, Huong Q. McLean, et al.
Vaccine (2019) Vol. 38, Iss. 8, pp. 2088-2094
Open Access | Times Cited: 4
Targeting of HA to chemokine receptors induces strong and cross-reactive T cell responses after DNA vaccination in pigs
Gunnveig Grødeland, Even Fossum, Bjarne Bogen
Vaccine (2019) Vol. 38, Iss. 6, pp. 1280-1285
Open Access | Times Cited: 4
Development and Characterization of a Multiplex Assay to Quantify Complement-Fixing Antibodies against Dengue Virus
Eduardo J. M. Nascimento, Brooke Norwood, Allan Parker, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 21, pp. 12004-12004
Open Access | Times Cited: 4
Hybrid immunity shifts the Fc-effector quality of SARS-CoV-2 mRNA vaccine-induced immunity
Kathryn Bowman, Daniel Stein, Sally Shin, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access | Times Cited: 2
Ad26.COV2.S priming provides a solid immunological base for mRNA-based COVID-19 booster vaccination
Daryl Geers, Roos S. G. Sablerolles, Debbie van Baarle, et al.
medRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access | Times Cited: 2
Monoklonal Antikorlar ve Tedavide Kullanımı
Muhammet Mükerrem KAYA, Hidayet Tutun
Turkish Journal of Agriculture - Food Science and Technology (2021) Vol. 9, Iss. 3, pp. 515-530
Open Access | Times Cited: 2
Gender Differences in Urothelial Bladder Cancer. Effects of Natural Killer Lymphocyte Immunity
Charles T. Lutz, Lydia Livas, Steven R. Presnell, et al.
(2021)
Open Access | Times Cited: 2

Scroll to top